EN
HI
Piramal Pharma Chart
Piramal Pharma Share Key Metrics
Volume
12.08 L
Market Cap
19001.60 CR
LTQ@LTP
134@145.54
ATP
145.47
Var Margin
18.09 %
Circuit Range
128.66-157.24
Delivery %
34.64 %
Value
17.57 CR
ASM/GSM
No
Market Lot
1
Summary
At 10 Apr, 2026 | 11:56, Piramal Pharma share price stands at ₹145.54, showing a 2.59% 1.81 for the day. The stock’s intraday movement has stayed between ₹143.25 and ₹146.70, while on a 52-week basis it has fluctuated from ₹132.30 to ₹228.45.
In terms of trading activity, Piramal Pharma has recorded a volume of 1207825 shares, with a market capitalisation of ₹1329248130. The stock’s Average Traded Price (ATP) stands at ₹14547, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 134,14554. The stock operates within a circuit range of ₹128.66-157.24, with a Value of ₹17.57 CR. The Delivery Percentage for the day is 34.64%. Additionally, Piramal Pharma currently falls under the No framework, and trades with a market lot size of 1.
Piramal Pharma Fundamentals
View MoreP/E Ratio
0
P/B Ratio
2.4
Div. Yield
0.1
Sector P/E
62.26
Sector P/B
3.36
Sec. Div. Yield
0.58
Piramal Pharma Resistance and Support
Pivot 143.61
Resistance
First Resistance
145.11
Second Resistance
147.28
Third Resistance
148.78
Support
First Support
141.44
Second Support
139.94
Third Support
137.77
Piramal Pharma Futures & Options
Piramal Pharma Option Chain
View Price, OI, Greeks & More...
28APR26
144.89
2.44 (1.71%)
PPLPHARMA|28APR26 CE 145.00
4.92
0.57 (13.1%)
PPLPHARMA|28APR26 PE 147.50
0
-5.08 (-100%)
Piramal Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-01-28 | Quarterly Results |
| 2025-11-05 | Quarterly Results |
| 2025-07-28 | Quarterly Results |
| 2025-05-14 | Audited Results & Final Dividend |
| 2025-01-28 | Quarterly Results |
Piramal Pharma News
Piramal Pharma Ltd - 543635 - Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015- Completion Of Acquisition Of Kenalog®, A Branded Commercial Injectable Product
Piramal Pharma's subsidiary, Piramal Critical Care B.V., completed the acquisition of Kenalog® from Bristol-Myers Squibb Company. This strengthens its Complex Hospital Generics portfolio and reinforces its presence in key markets like the US, Europe, and Asia Pacific.
Apr 01 2026 16:04:00
Piramal Pharma Ltd - 543635 - Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 - ESG Ratings
Piramal Pharma received an Environment, Social and Governance (ESG) Rating of '68.5' for FY 2024-25 from SES ESG Research Pvt. Ltd. This rating was voluntarily prepared by SES ESG using data available in the public domain, without the company's engagement.
Mar 20 2026 20:03:00
Read More
About Piramal Pharma
NSE : 11571
BSE : 543635
ISIN : INE0DK501011
Piramal Pharma Management
| Name | Position |
|---|---|
| Mrs. Nandini Piramal | Chairperson |
| Mr. Peter DeYoung | Executive Director |
Piramal Pharma Similar Stocks
Pfizer Ltd.
4832.00
82.90 (1.75%)
Wockhardt Ltd.
1361.60
-8.10 (0.59%)
Sai Life Sciences Ltd.
996.85
18.75 (1.92%)
Natco Pharma Ltd.
1112.80
-10.90 (0.97%)
Acutaas Chemicals Ltd.
2349.70
27.60 (1.19%)
Astrazeneca Pharma India Ltd.
8312.50
261.50 (3.25%)
Eris Lifesciences Ltd.
1369.30
5.20 (0.38%)
Neuland Laboratories Ltd.
14889.00
166.00 (1.13%)
Granules India Ltd.
641.20
5.70 (0.90%)
Onesource Specialty Pharma Ltd.
1392.30
16.60 (1.21%)
Piramal Pharma FAQs
The Buying Price of Piramal Pharma share is 145.54 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Piramal Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Piramal Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Piramal Pharma shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Piramal Pharma shares is 2.4. Useful to assess the stock's value relative to its book value.
To assess Piramal Pharma’s valuation compare Sector P/E, P/B which are 62.26 & 3.36 with sector averages, along with growth rates and financial metrics.
The Market Cap of Piramal Pharma is 19001.60 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Piramal Pharma share price is 228.45 & 132.30. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Piramal Pharma belongs to the Healthcare sector.
